Extended-cycle oral contraception: A new option for routine use

Treatments in Endocrinology

Volumn 4, Issue 3, 2005, Pages 139-145

  Nelson, Anita L ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL PLUS LEVONORGESTREL;

ABDOMINAL PAIN; CLINICAL TRIAL; DYSMENORRHEA; ENDOMETRIOSIS; ENDOMETRIUM; HEALTH CARE DELIVERY; HUMAN; MENSTRUATION; MIGRAINE; ORAL CONTRACEPTION; PATIENT CARE; PRIORITY JOURNAL; REVIEW; VAGINA BLEEDING;

ADULT; CHEMISTRY, PHARMACEUTICAL; CLINICAL TRIALS, PHASE III; CONTRACEPTIVES, ORAL; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MENSTRUAL CYCLE; MENSTRUATION; PATIENT SATISFACTION; TIME FACTORS; UTERINE HEMORRHAGE;

EID: 23044446156     PISSN: 11756349     EISSN: None     Source Type: Journal    
DOI: 10.2165/00024677-200504030-00002     Document Type: Review

References (37)

1. Marks L. Sexual chemistry: a history of the contraceptive pill. New Haven (CT): Yale University Press, 2001
2. Gladwell M. Annals of medicine. John Rock's error. What the co-inventor of the pill didn't know about menstruation can endanger women's health [online]. Available from URL: http://www.gladwell.com/archive.html [Accessed 2004 Sep 16]
3. Baerwald AR, Olatunbosun OA, Pierson RA. Ovarian follicular development is initiated during the hormone-free interval of oral contraceptive use. Contraception 2004 Nov; 70 (5): 371-7
4. Kistner RW. Current status of the hormonal treatment of endometriosis. Clin Obstet Gynecol 1966 Jun; 9 (2): 271-92
5. Vercellini P, Frontino G, De Giorgi O, et al. Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen. Fertil Steril 2003 Sep; 80 (3): 560-3
6. Boyle CA. Management of menstrual migraine. Neurology 1999; 53 (4 Suppl. 1): S14-8
7. Sommerville RI, Rogers WP. The nature and action of host signals. Adv Parasitol 1987; 26: 239-93
8. Mattson RH, Rebar RW. Contraceptive methods for women with neurologic disorders. Am J Obstet Gynecol 1993 Jun; 168 (6 Pt 2): 2027-32
9. Schwallie PC, Assenzo JR. Contraceptive use: efficacy study utilizing medroxyprogesterone acetate administered as an intramuscular injection once every 90 days. Fertil Steril 1973 May; 24 (5): 331-9
10. Sulak PJ, Scow RD, Preece C, et al. Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol 2000 Feb; 95 (2): 261-6
11. Sulak PJ, Kuehl TJ, Ortiz M, et al. Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdraw-al symptoms. Am J Obstet Gynecol 2002 Jun; 186 (6): 1142-9
12. Miller L, Notter KM. Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial. Obstet Gynecol 2001 Nov; 98 (5 Pt 1): 771-8
13. Miller L, Hughes JP. Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial. Obstet Gynecol 2003 Apr; 101 (4): 653-61
14. Kwiecien M, Edelman A, Nichols MD, et al. Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial. Contraception 2003 Jan; 67 (1): 9-13
15. Cote I, Jacobs P, Cumming D. Work loss associated with increased menstrual loss in the United States. Obstet Gynecol 2002 Oct; 100 (4): 683-7
16. Davis AR, Westhoff CL. Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives. J Pediatr Adolesc Gynecol 2001 Feb; 14 (1): 3-8
17. Thomas SL, Ellertson C. Nuisance or natural and healthy: should monthly menstruation be optional for women? Lancet 2000 Mar; 355 (9207): 922-4
18. Cote I, Jacobs P, Cumming DC. Use of health services associated with increased menstrual loss in the United States. Am J Obstet Gynecol 2003 Feb; 188 (2): 343-8
19. Elomaa K, Rolland R, Brosens I, et al. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation. Am J Obstet Gynecol 1998 Jul; 179 (1): 41-6
20. Schlaff WD, Lynch AM, Hughes HD, et al. Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression. Am J Obstet Gynecol 2004 Apr; 190 (4): 943-51
21. Spona J, Elstein M, Feichtinger W, et al. Shorter pill-free interval in combined oral contraceptives decreases follicular development. Contraception 1996 Aug; 54 (2): 71-7
22. Duramed Pharmaceuticals Inc. Seasonale® [prescribing information]. Pomona (NY): Duramed Pharmaceuticals Inc., 2003 Sep
23. Profet M. Menstruation as a defense against pathogens transported by sperm. Q Rev Biol 1993 Sep; 68 (3): 335-86
24. Coutinho EM, Segal SJ. Is menstruation obsolete? New York (NY): Oxford University Press, 1999
25. Brumberg JJ. The body's new timetable: how the life course of American girls has changed. ACOG Clin Rev 1998 Sep 10; 3 (5): 16, 13-5
26. Anderson FD, Hait H. A multicenter, randomized study of an extended cycle oral contraceptive. Contraception 2003 Aug; 68 (2): 89-96
27. Hamerlynck JV, Vollebregt JA, Doornebos CM, et al. Postponement of withdrawal bleeding in women using low-dose combined oral contraceptives. Contraception 1987 Mar; 35 (3): 199-205
28. Sulak PJ, Carl J, Gopalakrishnan I, et al. Outcomes of extended oral contraceptive regimens with a shortened hormone-free interval to manage breakthrough bleeding. Contraception 2004 Oct; 70 (4): 281-7
29. Rutter W, Knight C, Vizzard J, et al. Women's attitudes to withdrawal bleeding and their knowledge and beliefs about the oral contraceptive pill. Med J Aust 1988 Oct 17; 149 (8): 417-9
30. den Tonkelaar I, Oddens BJ. Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use. Contraception 1999 Jun; 59 (6): 357-62
31. Glasier AF, Smith KB, van der Spuy ZM, et al. Amenorrhea associated with contraception: an international study on acceptability. Contraception 2003 Jan; 67 (1): 1-8
32. Association of Reproductive Health Professionals. Choosing when to menstruate: the role of extended contraception. National Survey. Harris Poll, June 14-17 and July 18-22, 2002 [online]. Available from URL: http://www.arhp.org/ healthcareproviders/visitingfacultyprograms/extended/ nationalsurvey.cfm [Accessed 2004 Sep 25]
33. Wiegratz I, Hommel HH, Zimmermann T, et al. Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives. Contraception 2004 Jan; 69 (1): 37-42
34. Andrist LC, Arias RD, Nucatola D, et al. Women's and providers' attitudes toward menstrual suppression with extended use of oral contraceptives. Contraception 2004 Nov; 70 (5): 359-63
35. Loudon NB, Foxwell M, Potts DM, et al. Acceptability of an oral contraceptive that reduces the frequency of menstruation: the tri-cycle pill regimen. BMJ 1977 Aug 20; 2 (6085): 487-90
36. Braunstein JB, Hausfeld J, Hausfeld J, et al. Economics of reducing menstruation with trimonthly-cycle oral contraceptive therapy: comparison with standard-cycle regimens. Obstet Gynecol 2003 Oct; 102 (4): 699-708
37. Schwartz JL, Creinin MD, Pymar HC. The trimonthly combination oral contracep-tive regimen: is it cost effective? Contraception 1999 Nov; 60 (5): 263-7